EQL Pharma receives SEK 23 million order for covid self-test
Last spring, EQL Pharma announced an expansion of the product line to include an antigen covid-19 self-test (under the Boson brand) for its own use, and since October it has also had a saliva-based self-test (under the Alltest brand) available.During the year, the company successfully delivered these covid-19 antigen self-tests both in Sweden and internationally. The company has now received a major individual order for an antigen self-test with a sales value of approximately SEK 23 million. Revenue is expected to fall during EQL Pharma's fourth financial quarter (January-March).